Healthcare Medical Devices Biotechnology

Metabolic Testing Market

Global Industry Analysis and Forecast 2023-2030

Pages : 120

Base Year : 2022

Release Year : April 2024

Format : Pdf Ppt Xls

Report ID: KR326

Author : Omkar R.

Base Year

2022

Forecast Year

2023-2030

Historical Years

2018-2021

Market Value (2022)

USD 572.4 Million

Forecasted Value (2030)

USD 1001.4 Million

CAGR (2023 – 2030)

7.30%

Fastest Growing Region (2023 - 2030)

Asia Pacific

Largest Region

North America

By Application

Clinical Metabolic Testing, Sports and Fitness, Pharmaceutical Research, Metabolic Disorders Diagnosis, Respiratory Disorders

By Technology

Indirect Calorimetry, Body Composition Analysis, Isotope Dilution, Bioelectrical Impedance Analysis

By End-User

Hospitals and Clinics, Fitness Centers and Sports Institutes, Pharmaceutical and Biotechnology Companies, Research Institutes and Universities, Diagnostic Laboratories


infographics Img
CHOOSE LICENCE TYPE
CUSTOMIZATION OFFERED
  • Check Icon Additional Company Profiles
  • Check Icon Additional Countries
  • Check Icon Cross Segment Analysis
  • Check Icon Regional Market Dynamics
  • Check Icon Country-Level Trend Analysis
  • Check Icon Competitive Landscape Customization
  • Check Icon Extended Forecast Years
  • Check Icon Historical Data Up to 5 Years
Frequently Asked Questions (FAQ's)
The global metabolic testing market is projected to reach USD 1001.4 million by 2030, growing at a CAGR of 7.30% from 2023 to 2030.
The global metabolic testing market was valued at USD 572.4 million in 2022.
Rising awareness of preventive healthcare and an aging population seeking better healthcare services are significant market drivers for the global metabolic testing industry.
Top manufacturers of metabolic testing market are Cosmed Srl, Microlife Medical Home Solutions, Inc., Parvo Medics, CareFusion Corporation, Geratherm Respiratory GmbH, Vyaire Medical, Inc., KORR Medical Technologies, Inc., GE Healthcare, MGC Diagnostics Corporation, AEI Technologies, Inc., and others.
Asia-Pacific is the fastest growing region with the highest CAGR in the forecasted period (2023-2030).
By application, clinical metabolic testing segment will hold the maximum share in the metabolic testing market in 2030.
Get the latest!

Get actionable strategies to empower your business and market domination

  • Deliver Revenue Impact
  • Demand Supply Patterns
  • Market Estimation
  • Real-Time Insights
  • Market Intelligence
  • Lucrative Growth Opportunities
  • Micro & Macro Economic Factors
  • Futuristic Market Solutions
  • Revenue-Driven Results
  • Innovative Thought Leadership